Total Payments
$1,985
2024 Payments
$255.10
Companies
29
Transactions
79
Medicare Patients
5,429
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$1,759 (88.6%)
Education$226.01 (11.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,759 | 74 | 88.6% |
| Education | $226.01 | 5 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pinnacle Biologics, Inc | $194.65 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $173.33 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $171.82 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $166.64 | 8 | $0 (2018) |
| Bard Peripheral Vascular, Inc. | $148.58 | 1 | $0 (2023) |
| Medtronic, Inc. | $126.97 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $109.17 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $104.82 | 6 | $0 (2021) |
| Janssen Products, LP | $99.95 | 1 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $86.76 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.10 | 7 | Pinnacle Biologics, Inc ($194.65) |
| 2023 | $206.26 | 5 | Bard Peripheral Vascular, Inc. ($148.58) |
| 2022 | $184.64 | 7 | Medtronic, Inc. ($126.97) |
| 2021 | $136.10 | 7 | Merck Sharp & Dohme Corporation ($61.02) |
| 2020 | $28.21 | 2 | Celgene Corporation ($14.43) |
| 2019 | $206.47 | 2 | AstraZeneca Pharmaceuticals LP ($131.48) |
| 2018 | $370.41 | 18 | Janssen Products, LP ($99.95) |
| 2017 | $598.08 | 31 | E.R. Squibb & Sons, L.L.C. ($119.22) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/04/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $26.59 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $124.56 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $43.50 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $10.20 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/20/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/02/2023 | Bard Peripheral Vascular, Inc. | GlidePath (Device) | Food and Beverage | In-kind items and services | $148.58 | General |
| Category: Vascular/Oncology | ||||||
| 10/25/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 09/06/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 07/19/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 10/26/2022 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Hematology | ||||||
| 08/25/2022 | Medtronic, Inc. | BEACON (Device) | Food and Beverage | In-kind items and services | $106.30 | General |
| Category: Endoscopic Ultrasound | ||||||
| 08/25/2022 | Medtronic, Inc. | BEACON (Device) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Endoscopic Ultrasound | ||||||
| 08/22/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Oncology | ||||||
| 08/16/2022 | Medtronic, Inc. | BEACON (Device) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Endoscopic Ultrasound | ||||||
| 05/10/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Oncology | ||||||
| 04/27/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Oncology | ||||||
| 11/04/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2021 | PFIZER INC. | XALKORI (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Oncology | ||||||
| 05/25/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Oncology | ||||||
| 05/06/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2021 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,050 | 44,966 | $1.3M | $565,641 |
| 2022 | 37 | 1,359 | 75,953 | $1.3M | $571,333 |
| 2021 | 36 | 1,425 | 47,795 | $1.6M | $674,589 |
| 2020 | 43 | 1,595 | 64,796 | $1.5M | $590,431 |
Total Patients
5,429
Total Services
233,510
Medicare Billing
$2.4M
Procedure Codes
151
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 14 | 10,200 | $754,420 | $352,746 | 46.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 3,240 | $103,680 | $59,665 | 57.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 472 | $98,176 | $42,872 | 43.7% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 32 | 27,000 | $71,250 | $23,700 | 33.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 59 | 191 | $48,323 | $17,802 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 124 | $34,844 | $16,848 | 48.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $24,986 | $9,757 | 39.0% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 12 | 1,280 | $32,000 | $7,260 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 94 | $13,254 | $5,468 | 41.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 91 | $12,740 | $4,844 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 64 | $17,490 | $4,604 | 26.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 64 | 93 | $12,090 | $4,156 | 34.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 27 | $5,535 | $2,474 | 44.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 45 | 101 | $5,858 | $2,153 | 36.8% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 20 | 39 | $4,563 | $1,840 | 40.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 65 | 160 | $7,680 | $1,617 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 23 | $3,368 | $1,401 | 41.6% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 35 | 61 | $2,806 | $1,020 | 36.4% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 13 | 57 | $2,052 | $868.78 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 20 | $3,820 | $810.15 | 21.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 24 | 68 | $2,856 | $777.06 | 27.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 12 | 30 | $1,620 | $605.31 | 37.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 12 | 85 | $13,430 | $596.39 | 4.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 22 | $1,342 | $549.78 | 41.0% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 11 | 22 | $2,354 | $526.68 | 22.4% |
About Dr. Mohammad Rashid, MD
Dr. Mohammad Rashid, MD is a Hematology & Oncology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477545655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Rashid, MD has received a total of $1,985 in payments from pharmaceutical and medical device companies, with $255.10 received in 2024. These payments were reported across 79 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,759).
As a Medicare-enrolled provider, Rashid has provided services to 5,429 Medicare beneficiaries, totaling 233,510 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Toledo, OH
- Active Since 08/16/2005
- Last Updated 01/26/2026
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1477545655
Products in Payments
- Photofrin (Drug) $194.65
- OPDIVO (Biological) $166.64
- GlidePath (Device) $148.58
- TAGRISSO (Drug) $131.48
- BEACON (Device) $126.97
- ZYTIGA (Drug) $111.94
- KEYTRUDA (Biological) $90.98
- Erleada (Drug) $90.33
- NINLARO (Drug) $86.76
- ERLEADA (Drug) $71.01
- Rezlidhia (Drug) $67.88
- Kyprolis (Biological) $42.73
- ADCETRIS (Biological) $37.76
- Imbruvica (Drug) $37.05
- Avastin (Biological) $30.66
- CYRAMZA (Drug) $27.94
- FASLODEX (Drug) $27.46
- Cabometyx (Drug) $26.49
- ZEJULA (Drug) $22.75
- RYDAPT (Drug) $21.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Toledo
Dr. Rex Mowat, Md, MD
Hematology & Oncology — Payments: $122,388
Hematology & Oncology $122,388
Ahmad Zarzour, M.d, M.D
Hematology & Oncology — Payments: $23,407
Hematology & Oncology $23,407
Dr. David Brown, Md, MD
Hematology & Oncology — Payments: $2,105
Hematology & Oncology $2,105
Dr. Danae Hamouda, M.d, M.D
Hematology & Oncology — Payments: $1,239
Hematology & Oncology $1,239
Timothy Kasunic, Md, MD
Hematology & Oncology — Payments: $956.37
Hematology & Oncology $956.37
Abhay Shelke, Md, MD
Hematology & Oncology — Payments: $665.04
Hematology & Oncology $665.04